aTyr Pharma Inc. (LIFE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.30-0.03 (-0.90%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close3.33
Bid2.86 x 400
Ask3.50 x 400
Day's Range3.21 - 3.40
52wk Range2.48 - 13.26
1y Target EstN/A
Market Cap78.27M
P/E Ratio (ttm)-1.32
Avg Vol (3m)227,630
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire4 days ago

    aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research

    SAN DIEGO, Sept. 21, 2016 /PRNewswire/ -- aTyr Pharma, Inc. (LIFE), today announced that David J. King, PhD, has joined the company as Senior Vice President, Research. Dr. King will lead aTyr's research and preclinical efforts to advance its Physiocrine biology and support the clinical development of meaningful medicines that target immune and tissue homeostatic pathways for patients with various severe and rare diseases. "Dr. King is uniquely qualified to help us execute on our mission to bring Physiocrine-based therapeutic candidates to patients with severe and rare diseases," said John Mendlein, PhD, Chief Executive Officer of aTyr Pharma.

  • TheStreet.com11 days ago

    7 Stocks Under $10 Making Big Moves Higher

    When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

  • Associated Press2 months ago

    Atyr Pharma reports 2Q loss

    The San Diego-based company said it had a loss of 65 cents per share. In the final minutes of trading on Wednesday, the company's shares hit $2.98. A year ago, they were trading at $18.13. _____ This story ...